A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

• المؤلفون الرئيسيون: Eun-Seok Jeon (مؤلف), Sang Wook Lim (مؤلف), Seok-Yeon Kim (مؤلف), Hyoung-Mo Yang (مؤلف), Moo Hyun Kim (مؤلف), Moo-Yong Rhee (مؤلف), Seung Hwan Han (مؤلف), Jinho Shin (مؤلف), Kwang-il Kim (مؤلف), Jin-Ok Jeong (مؤلف), Ki Chul Sung (مؤلف), Geu Ru Hong (مؤلف), Hyung-Seop Kim (مؤلف), Kihwan Kwon (مؤلف), Tae-Soo Kang (مؤلف), Hae-Young Lee (مؤلف), Su-Eun Han (مؤلف)
• التنسيق: كتاب
• منشور في: BMC, 2022-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Background To assess the efficacy and safety of a combination therapy involving fimasartan, amlodipine, and rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond to fimasartan monotherapy. Methods This phase III, randomized, double-blind, multicenter stud...